“Integration of AI and Advanced Monitoring Technologies”
- Adoption of AI-Enhanced Monitoring: The North American market is witnessing a surge in the integration of artificial intelligence (AI) into anesthesia monitoring devices. These advancements enable real-time data analysis, enhancing patient safety and optimizing anesthesia delivery during surgical procedures.
- For instance, Europe accounted for 40.8% of the global Orthobiologics market, with the U.S. contributing significantly to this share. In 2025, the market is expected to reach USD 6.04 billion and grow to USD 8.51 billion by 2030, driven by increased surgical procedures and advanced anesthesia technologies.
- Shift Towards Minimally Invasive Procedures: There's a growing preference for minimally invasive surgeries, which require sophisticated Orthobiologics capable of precise control and monitoring, thereby driving demand for advanced equipment in the region.
